PharmaShots Interview: IMV’s Andrew Hall Shares Insight on DPX Technology for Bladder and Ovarian Cancer

In an interview with PharmaShots, Andrew Hall, CEO at IMV share his views on the data of DPX delivery platform in the bladder and ovarian cancer, presented in two e-posters at the AACR-NCI-EORTC virtual conferenceShots:The company has reported additional data to support the immunotherapeutic capabilities of its DPX technology. In pre-clinical/clinical data, DPX technology generates peptide-specific, T cell-based immune…

BySenior EditorDecember 28, 2021

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – June 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop itThe outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019.PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where…

BySenior EditorJune 30, 2020

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop itThe outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where…

BySenior EditorMay 29, 2020

PharmaShots Interview: IMV’s Andrew Hall Shares Insight on DPX Technology for Bladder and Ovarian Cancer

Insights+: COVID-19 Healthcare News Monthly Updates – June 2020

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Contact US

FOLLOW US